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Endothelin-1–induced contraction in cerebral vessels mediated
by phospholipase C/protein kinase C cascade. Endothelin (ET)
vasoconstricts cerebral vessels potently, an effect mediated by
ETA receptors on the smooth muscle, although the subsequent
signaling cascade is unclear. We tested whether the action of ET-1
is mediated by the phospholipase C (PLC)/protein kinase C
(PKC) cascade. Isometric force was measured in vitro in ring
segments of rat basilar (BA) and middle cerebral (MCA) arteries
and expressed as a percentage of the contraction to 124 mM K1.
Concentration-effect curves for the constrictor effect of ET-1 (1
pM 5 0.3 mM) in control segments or after 25 minutes preincuba-
tion with an inhibitor of PLC (neomycin 100 mM) or PKC (H7 10
mM) were constructed under resting tone. In untreated BA, 100
nM ET-1 induced a contraction of 119 6 5.3% that fell signifi-
cantly to 97 6 2.8% and 98 6 6.7% after neomycin or H7
pretreatment, respectively. In MCA, 100 nM ET-1 induced a
contraction of 105 6 3.2% that fell significantly to 93 6 6.3% and
64 6 8.1% after neomycin or H7, respectively. There was no
significant shift of the ET-1 EC50 after PKC inhibition in either
vessel or PLC inhibition in BA. In summary, the amplitude of
ET-1–induced contraction in cerebral vessels is reduced signifi-
cantly, whereas the sensitivity to the agonist is unchanged, after
blocking PLC with neomycin or PKC with H7. This indicates
noncompetitive inhibition. ET-1–induced contraction in cerebral
vessels thus depends on activation of the PLC/PKC cascade.
Endothelins (ETs) dilate and constrict potently in the
cerebral circulation. ET-1 is predominantly a vasoconstric-
tor [1]. In the isolated rat basilar artery (BA), dilation
becomes evident only after precontraction and additional
blockade of the ETA receptor [2]. In vivo, minor dilation of
pial arteries has been observed on exposure to 100 pM ET-1
[3, 4]. In the rat BA, ET-3 dilates at low concentrations
(100 pM–10 nM) but constricts at higher concentrations if
vessels are precontracted [5]. These opposite effects have
been attributed to two different types of ET receptors: ETA
and ETB. The ETA receptor has a higher affinity for ET-1
and ET-2 than for ET-3, whereas the ETB receptor is
nonselective in this respect. The vascular ETA receptor
mediating vasoconstriction is located on the smooth muscle
cell [6, 7], whereas the vascular ETB receptor mediating
relaxation is on the endothelial cell and is coupled to
endothelial production of nitric oxide [5]. There is also
evidence for a contraction-mediating ETB2 receptor sub-
type [8]. This study examines whether the ET-1–induced
constriction of cerebral vessels via the ETA receptor is
mediated by activation of phospholipase C (PLC) and
protein kinase C (PKC).
METHODS
Male Wistar-Kyoto rats (280 to 320 g) were anesthetized
with 6.9 mg/kg xylazine (Bayer, Leverkusen, Germany) and
30 mg/kg ketamine (Parke Davis, Berlin, Germany). Ring
segments of middle cerebral artery (MCA) and BA were
prepared for measurement of isometric force as described
by Feger et al [1]. Segments were transferred into 5-ml
organ baths containing modified Krebs-Ho¨gesta¨tt solution
(in mM): NaCl, 119; KCl, 4.6; NaH2PO4, 1.2; CaCl2, 1.5;
MgCl2, 1.2; NaHCO3, 15; glucose, 10. The bath solution
was bubbled continuously with humidified 90% O2/10%
CO2 to give a pH of approximately 7.30 at 37°C. The ring
segments were mounted on two L-shaped wires (70 mm
diameter stainless-steel for BA; 50 æm diameter tungsten
for MCA), one of which was connected rigidly to the bath
and the second to a force transducer. Concentration-effect
curves were constructed under resting tone for the constric-
tor effect of ET-1 (1 pM 5 0.3 mM) in untreated control
segments and after 25 minutes preincubation with a PLC
inhibitor (neomycin, 100 mM) or with a PKC inhibitor (H7,
10 mM). Contractions are expressed as a percentage (mean
6 SEM) of the contraction induced by 124 mM K1. The pD2
(2log EC50) was calculated individually for each segment.
Statistical analysis was performed by Duncan’s test. P ,
0.05 was regarded as significant.
RESULTS AND DISCUSSION
Endothelin-1 vasoconstricted BA and MCA concentra-
tion dependently with maxima of 119% 6 5.3 and 105% 6
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3.2% at 100 nM and pD2 values of 8.76 6 0.25 and 8.36 6
0.09, respectively. Preincubation with the ETA-receptor
antagonist RO-61-1790 shifted the concentration-effect
curves for ET-1 in both vessels to the right without
attenuating the maximal response, indicating competitive
antagonism. This confirms that in rat cerebral vessels, the
ETA receptor mediates endothelin-dependent vasocon-
striction [1]. Preincubation of BA or MCA with neomycin
or H7 weakened the ET-1–elicited contraction over the
whole concentration range. In BA, the maximum response
fell significantly to 97 6 2.8% and 98 6 6.7% with pD2
values of 8.47 6 0.01 and 8.51 6 0.17 after neomycin or H7
pretreatment, respectively. In MCA, the maximum fell to
93 6 6.3% (pD2 7.80 6 0.07) after neomycin and to 64 6
8.1% (pD2 8.56 6 0.11) after H7. Because the maximum
amplitudes, but not the pD2, for both vessels fell, H7 blocks
the ET-1–mediated constriction noncompetitively. Neomy-
cin inhibits ET-1 in BA noncompetitively, but in the MCA,
both pD2 and the maximum response decreased. ET-1–
induced contraction of BA and MCA thus depends on ETA
receptor-mediated activation of the PLC/PKC cascade.
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Fig. 1. Concentration-effect curves for the vasoconstriction of rat basilar
artery rings elicited by endothelin-1 (ET-1) in the absence (control) or
presence of H7 or neomycin. *, #P , 0.05 versus control for neomycin and
H7, respectively. Symbols are: (v) control; (M) H7 preincubation; (V)
neomycin preincubation.
Fig. 2. Concentration-effect curves for the vasoconstriction of rat middle
cerebral artery rings elicited by endothelin-1 (ET-1) in the absence
(control) or presence of H7 or neomycin. *, #P , 0.05 versus control for
neomycin and H7, respectively. Symbols are: (v) control; (M) H7
preincubation; (V) neomycin preincubation.
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